N
CADX

Natixis’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Natixis’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-11,400
Closed -$105K – 645
2013
Q4 		$105K Buy
11,400
+500
+5% +$4.61K ﹤0.01% 498
2013
Q3 		$69K Buy
+10,900
New +$69K ﹤0.01% 461